Correlation Between Arrowhead Pharmaceuticals and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Eyenovia, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Eyenovia.
Diversification Opportunities for Arrowhead Pharmaceuticals and Eyenovia
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Arrowhead and Eyenovia is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Eyenovia go up and down completely randomly.
Pair Corralation between Arrowhead Pharmaceuticals and Eyenovia
Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to generate 0.23 times more return on investment than Eyenovia. However, Arrowhead Pharmaceuticals is 4.39 times less risky than Eyenovia. It trades about 0.07 of its potential returns per unit of risk. Eyenovia is currently generating about -0.23 per unit of risk. If you would invest 2,018 in Arrowhead Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 87.00 from holding Arrowhead Pharmaceuticals or generate 4.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arrowhead Pharmaceuticals vs. Eyenovia
Performance |
| Timeline |
| Arrowhead Pharmaceuticals |
| Eyenovia |
Arrowhead Pharmaceuticals and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arrowhead Pharmaceuticals and Eyenovia
The main advantage of trading using opposite Arrowhead Pharmaceuticals and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.The idea behind Arrowhead Pharmaceuticals and Eyenovia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Eyenovia vs. Capricor Therapeutics | Eyenovia vs. Soleno Therapeutics | Eyenovia vs. Bio Path Holdings | Eyenovia vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |